Skip to main content
. 2022 Mar;24(3):274–286. doi: 10.1016/j.jmoldx.2021.12.002

Table 5.

Frequency of Phenotype Subcategories for CES Testing

Phenotype subcategory Value, n (%)
CNS involvement 446 (63.7)
Developmental delay 329 (54.4)
Neuromuscular/musculoskeletal 322 (46.0)
Structural birth defect(s) 236 (33.7)
Growth abnormality 210 (30.0)
Craniofacial involvement/dysmorphic features 209 (29.9)
Abnormal muscle tone 172 (24.6)
Gastrointestinal 155 (22.1)
Skeletal 123 (17.6)
Seizures 119 (17.0)
Abnormal brain MRI 115 (16.4)
Cardiovascular 108 (15.4)
Ophthalmologic 104 (14.9)
Audiologic/otolaryngolic 83 (11.9)
Respiratory/pulmonary 82 (11.7)
Microcephaly 80 (11.4)
Immunodeficiency (rare and/or recurrent infections) 78 (11.1)
Neurologic movement disorder (ataxia/spasticity, tremor, dystonia, parkinsonism, or myoclonus) 69 (9.9)
Autism spectrum disorder 66 (9.4)
Endocrine 63 (9.0)
Connective tissue 59 (8.4)
Hematological/vascular 58 (8.3)
Genitourinary 49 (7.0)
Renal 47 (6.7)
Integumentary (includes hair, skin, and nails) 42 (6.0)
Syndromic intellectual disability 42 (6.0)
Metabolic/biochemical 39 (5.6)
Macrocephaly 35 (5.0)
Autoimmune disease 34 (4.9)
Muscular dystrophy and/or myopathy 32 (4.6)
Liver 31 (4.4)
Joint contracture/arthrogryposis multiplex congenita 23 (3.3)
Oncologic 16 (2.3)
Neuropathy 15 (2.1)
Allergies 15 (2.1)
Abnormality of spinal cord/neural tube 13 (1.9)
Nonsyndromic intellectual disability 11 (1.6)
Obstetric 11 (1.6)
Dental 6 (0.9)

Individual clinical features were listed in 39 subcategories. Each patient was assigned to one or more subcategories.

CES, clinical exome sequencing; CNS, central nervous system; MRI, magnetic resonance imaging.